March 18, 2023
PR Newswire
Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata
MUMBAI, India and PRINCETON, N.J. , March 18, 2023 /PRNewswire/ -- Concert Pharmaceuticals ("Concert"... See more »